56th ASH Annual Meeting to highlight latest research, celebrate milestones in hematology

December 02, 2014

(WASHINGTON, Dec. 2, 2014) - The American Society of Hematology (ASH) will host more than 20,000 attendees from around the world for its 56th annual meeting, featuring breakthrough research and the latest patient care advances in hematology December 6-9 at the Moscone Center in San Francisco. This ASH meeting is the premier annual event for physicians and scientists in hematology.

The 2014 ASH Annual Meeting will feature nearly 5,000 (4,871) scientific abstract presentations representing the entire hematology research continuum - from critical basic laboratory work to late-stage clinical trials. Six of the top-scoring abstracts will be highlighted during the Plenary Scientific Session on Sunday; the Late-Breaking Abstracts Session on Tuesday will showcase six studies with novel, late-breaking data of high impact. To complement the meeting's hallmark oral and poster presentations, two "Featured Topic Discussion" sessions will be offered featuring expert analysis of several abstract presentations in the timely areas of hemostasis and thrombosis and "checkpoint blockade" therapies.

In addition to its highly anticipated abstract presentations, the 2014 ASH Annual Meeting program includes notable sessions on the promise and optimal use of new drugs entering the marketplace. A special session on newly approved drugs, moderated by ASH Clinical News Editor-in-Chief Mikkael Sekeres, MD, will feature analysis from experts with significant clinical experience using these new therapies. This year's Special Symposium on Quality, titled "The Rising Cost of Medical Care: Understand the Problem and Exploring Solutions," will address how the financial burden of cancer drugs in particular can negatively affect patient treatment adherence and quality of life.

Other signature annual meeting offerings include the Education and Scientific Programs; a host of lectures, seminars, and special symposia; and presentations of the Society's honorific and mentor awards: "The ASH annual meeting showcases the full spectrum of translation in hematology," said ASH President Linda J. Burns, MD, of the University of Minnesota. "The programming is exceptionally diverse, as session topics span from basic research discoveries to exciting new therapies that improve patient outcomes. We have worked hard to ensure that there is great programming for everyone, no matter their focus within the field."

For the complete annual meeting program and abstracts, visit http://www.hematology.org/annual-meeting. Up-to-the-minute meeting information can also be found by following ASH on Twitter (@ash_hematology) and the hashtag #ASH14.
The American Society of Hematology (ASH) (http://www.hematology.org) is the world's largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. The official journal of ASH is Blood(http://www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online.

American Society of Hematology

Related Physicians Articles from Brightsurf:

Needlestick, sharps injuries among resident physicians
Rates and characteristics of needle stick and other sharps injuries among resident physicians and other staff at a large health care center were examined in this study.

Prevalence of suicide-related behaviors among physicians
An analysis of published studies has found a relatively high prevalence of suicidal behaviors among physicians.

To support lactating emergency physicians, consider these strategies
A new paper highlights strategies that emergency departments can implement to support lactating emergency physicians.

Physicians call for an end to conversion therapy
Historically, conversion therapies have used electroshock therapy, chemical drugs, hormone administrations and even surgery.

Racial bias associated with burnout among resident physicians
Symptoms of physician burnout appear to be associated with greater bias toward black people in this study of nearly 3,400 second-year resident physicians in the United States who identified as nonblack.

Survey finds physicians struggle with their own self-care
Despite believing that self-care is a vitally important part of health and overall well-being, many physicians overlook their own self-care, according to a new survey released today, conducted by The Harris Poll on behalf of Samueli Integrative Health Programs.

Less burnout seen among US physicians, Stanford researcher says
The epidemic levels of physicians reporting burnout dropped modestly in 2017, according to a study by researchers at the Stanford University School of Medicine, the Mayo Clinic and the American Medical Association.

Payments to physicians may increase opioid prescribing
US doctors who receive direct payments from opioid manufacturers tend to prescribe more opioids than doctors who receive no such payments, according to new research published by Addiction.

Is marketing of opioids to physicians associated with overdose deaths?
This study examined the association between pharmaceutical company marketing of opioids to physicians and subsequent death from prescription opioid overdoses across US counties.

Nearly half of resident physicians report burnout
Resident physician burnout in the US is widespread, with the highest rates concentrated in certain specialties, according to research from Mayo Clinic, OHSU and collaborators.

Read More: Physicians News and Physicians Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.